 | This article is rated Stub-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | ||||||||||
| |||||||||||
 | Ideal sources for Wikipedia's health content are defined in the guideline
Wikipedia:Identifying reliable sources (medicine) and are typically
review articles. Here are links to possibly useful sources of information about Niacin/lovastatin.
|
Drug approval withdrawn in U.S. in 2016. Reason given was trials that did not show benefit of Advicor over just lovastatin (Mevacor). David notMD ( talk) 13:09, 17 May 2020 (UTC)
|
| This article is rated Stub-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | ||||||||||
| |||||||||||
|
| Ideal sources for Wikipedia's health content are defined in the guideline
Wikipedia:Identifying reliable sources (medicine) and are typically
review articles. Here are links to possibly useful sources of information about Niacin/lovastatin.
|
Drug approval withdrawn in U.S. in 2016. Reason given was trials that did not show benefit of Advicor over just lovastatin (Mevacor). David notMD ( talk) 13:09, 17 May 2020 (UTC)